archive-ie.com » IE » N » NCPE.IE

Total: 381

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • Latest Drugs | National Centre for Pharmacoeconomics - Part 15
    Research ICORN Education Latest Drugs In this Section Pharmacoeconomic Evaluations Drugs Latest Drugs Vaccines Diagnostics and Other Technologies Archive Decitabine Dacogen December 21 2012 Bendamustine Levact December 13 2012 Eribulin Halaven December 7 2012 Ingenol mebutate gel Picato December 6 2012 Axitinib Inlyta November 20 2012 C1inhibitor human Cinryze November 15 2012 Aclidinium bromide Eklira Genuair October 30 2012 Everolimus Afinitor October 15 2012 Ceftaroline Zinforo October 15 2012 Vemurafenib

    Original URL path: http://www.ncpe.ie/pharmacoeconomic-evaluations/all-drug/drugs/page/15/ (2015-10-30)
    Open archived version from archive

  • Latest Drugs | National Centre for Pharmacoeconomics - Part 16
    Archive Fampridine Fampyra August 17 2012 Ferumoxytol Rienso August 17 2012 Glycopyrronium bromide Seebri Breezhaler August 17 2012 Capsaicin 8 w w patch Qutenza July 2 2012 Apixaban Eliquis for the prevention of venous thromboembolic events in adult patients who have undergone elective hip or knee replacement surgery June 19 2012 Rivaroxaban Xarelto for the Prevention of Stroke in Atrial Fibrillation June 19 2012 Piperaquine tetraphosphate dihidroartemisinin Eurartesim May 28

    Original URL path: http://www.ncpe.ie/pharmacoeconomic-evaluations/all-drug/drugs/page/16/ (2015-10-30)
    Open archived version from archive

  • Latest Drugs | National Centre for Pharmacoeconomics - Part 18
    ICORN Education Latest Drugs In this Section Pharmacoeconomic Evaluations Drugs Latest Drugs Vaccines Diagnostics and Other Technologies Archive Amifampridine Firdapse December 9 2011 Denosumab Xgeva December 8 2011 Lotemax 0 5 eye drops suspension Loteprednol December 5 2011 Regadenoson Rapiscan November 2 2011 Everolimus Votubia October 14 2011 Grass pollen allergen extract Oralair October 13 2011 Ticagrelor Brilique October 11 2011 Fingolimod Gilenya September 22 2011 Tadalafil Adcirca September 21

    Original URL path: http://www.ncpe.ie/pharmacoeconomic-evaluations/all-drug/drugs/page/18/ (2015-10-30)
    Open archived version from archive

  • Latest Drugs | National Centre for Pharmacoeconomics - Part 21
    ICORN Education Latest Drugs In this Section Pharmacoeconomic Evaluations Drugs Latest Drugs Vaccines Diagnostics and Other Technologies Archive Iron isomaltoside 1000 MonoVer February 2 2011 Bazedoxifene Conbriza January 2 2011 Pitavastatin Livazo December 29 2010 Tobramycin TOBI Podhaler November 29 2010 Gefitinib Iressa November 5 2010 Eltrombopag Revolade November 4 2010 Roflumilast Daxas November 3 2010 Corifollitropin alfa Elonva October 22 2010 Nilotinib Tasigna newly diagnosed CML October 22 2010

    Original URL path: http://www.ncpe.ie/pharmacoeconomic-evaluations/all-drug/drugs/page/21/ (2015-10-30)
    Open archived version from archive

  • Latest Drugs | National Centre for Pharmacoeconomics - Part 22
    Research ICORN Education Latest Drugs In this Section Pharmacoeconomic Evaluations Drugs Latest Drugs Vaccines Diagnostics and Other Technologies Archive Certolizumab pegol Cimzia September 1 2010 Denosumab Prolia July 18 2010 Mifamurtide Mepact July 13 2010 Oral Oxycodone naloxone Targin July 13 2010 Ofatumumab Arzerra Refractory CLL June 22 2010 Golimumab Simponi May 11 2010 Colesevelam Cholestagel March 22 2010 Prasugrel Efient February 1 2010 Indacaterol Onbrez January 15 2010 Dronedarone

    Original URL path: http://www.ncpe.ie/pharmacoeconomic-evaluations/all-drug/drugs/page/22/ (2015-10-30)
    Open archived version from archive

  • Latest Drugs | National Centre for Pharmacoeconomics - Part 23
    Drugs In this Section Pharmacoeconomic Evaluations Drugs Latest Drugs Vaccines Diagnostics and Other Technologies Archive Agomelatine Valdoxan December 11 2009 Ustekinumab Stelara December 8 2009 Adenuric Febuxostat December 8 2009 Ranolazine Ranexa November 19 2009 Degarelix Firmagon October 15 2009 Liraglutide Victoza October 7 2009 Eslicarbazepine Zebinix September 1 2009 Glucosamine sulfate Dona July 7 2009 Sapropterin Kuvan June 18 2009 Rivaroxaban Xarelto for the Primary Prevention of Venous Thromboembolic

    Original URL path: http://www.ncpe.ie/pharmacoeconomic-evaluations/all-drug/drugs/page/23/ (2015-10-30)
    Open archived version from archive

  • Latest Drugs | National Centre for Pharmacoeconomics - Part 19
    Drugs In this Section Pharmacoeconomic Evaluations Drugs Latest Drugs Vaccines Diagnostics and Other Technologies Archive Catumaxomab Removab September 6 2011 Dexmedetomidine Dexdor September 6 2011 Hydroxycarbamide Siklos September 6 2011 Ipilimumab Yervoy September 6 2011 Linagliptin Trajenta September 6 2011 Belimumab Benlysta August 13 2011 Dabigatran etexilate Pradaxa for the prevention of stroke and systematic embolisom in atrial fibrillation August 9 2011 Lornoxicam Xefo July 7 2011 Nepafenac Nevanac June

    Original URL path: http://www.ncpe.ie/pharmacoeconomic-evaluations/all-drug/drugs/page/19/ (2015-10-30)
    Open archived version from archive

  • Drugs | National Centre for Pharmacoeconomics - Part 3
    Research Pharmacoeconomic Research ICORN Education Drugs In this Section Pharmacoeconomic Evaluations Drugs Latest Drugs Vaccines Diagnostics and Other Technologies Archive A B C D E F G H I L M N O P R S T U V Apremilast Otezla for psoriatic arthritis Aripiprazole Abilify Maintena Asenapine Sycrest Aspirin 81mg Esomeprazole 20mg Axanum Ataluren Translarna Avanafil Spedra Axitinib Inlyta Azelastine hydrochloride and fluticasone propionate nasal spray Dymista Azilsartan Edarbi

    Original URL path: http://www.ncpe.ie/category/drugs/page/3/ (2015-10-30)
    Open archived version from archive